Health FDA Panel Narrowly Backs Dostarlimab Trial Plans in Rectal Cancer Eli Pacheco Feb 10, 2023 0 While expressing reservations, an advisory committee to the FDA backed clinical development…
Health FDA Has Concerns on ‘Unprecedented’ Plan for Dostarlimab in Rectal… Eli Pacheco Feb 9, 2023 0 The FDA's Oncologic Drugs Advisory Committee (ODAC) will meet Thursday and vote on whether…
Health FDA Grants Tissue-Agnostic Approval to Dostarlimab for dMMR Tumors Eli Pacheco Aug 19, 2021 0 The FDA granted a fifth tissue-agnostic indication, expanding approved use of the PD-1…